What is Exagen Inc.'s R&D?

Exagen Inc. (XGN) reported R&D of $1.55M in Q1 2026.

How has Exagen Inc.'s R&D changed year-over-year?

Exagen Inc.'s R&D increased by 21.0% year-over-year, from $1.28M to $1.55M.

What is the long-term trend for Exagen Inc.'s R&D?

Over 4 years (2021 to 2025), Exagen Inc.'s R&D has grown at a -3.6% compound annual growth rate (CAGR), from $7.24M to $6.25M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Exagen Inc. XGN R&D

R&D at other companies

Insight Molecular Diagnostics Inc. Common StockIMDX

$4.95M+69.4%

Vor BiopharmaVOR

$17.6M-34.1%

Avalo TherapeuticsAVTX

$14.05M+54.0%

CareDxCDNA

$21.42M+15.6%

Bio-Rad LaboratoriesBIO

$62.9M-14.4%

RevvityRVTY

$57.89M+8.0%

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-28.2%

Enterprise value$117.78M-22.1%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s R&D?: Exagen Inc. (XGN) reported R&D of $1.55M in Q1 2026.
How has Exagen Inc.'s R&D changed year-over-year?: Exagen Inc.'s R&D increased by 21.0% year-over-year, from $1.28M to $1.55M.
What is the long-term trend for Exagen Inc.'s R&D?: Over 4 years (2021 to 2025), Exagen Inc.'s R&D has grown at a -3.6% compound annual growth rate (CAGR), from $7.24M to $6.25M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.